Aesthetic Medicine Symposium - November 14-16 in Scottsdale, AZ!Register Now
Celebrating 20 Years of Excellence in Botox®, Aesthetic Medicine & Medical Weight Management Training & Certification
Aesthetic Medicine Symposium — Nov 14–16, Scottsdale, AZ Register Now →
Empowering Medical Aesthetic Clinics, Practitioners, and Patients
Droopy Eyelid After Botox® (Ptosis): Causes, Remedies, Duration, and Prevention
Last updated: September 2026
Botox® is one of today’s most popular cosmetic treatments for smoothing facial wrinkles and refreshing the appearance of the upper face. It is generally safe in trained hands — but one side effect is worth understanding properly before treatment, because it is far more common than most patients are told: a droopy upper eyelid, known clinically as eyelid ptosis.
Most articles call it rare. The FDA prescribing information does not. In Botox® Cosmetic’s own label, eyelid ptosis is listed at 3% for glabellar (frown line) treatment, where it is the single most commonly reported adverse reaction. That is not a reason to avoid treatment — it is a reason to understand the facial anatomy behind the injection sites, because the difference between a good result and a heavy eyelid is almost entirely a matter of where the needle goes and how much product is placed there.
Whether you are a patient trying to work out what happened, a provider managing a complication, or a clinic writing patient education, here is what the evidence actually says — why ptosis happens, how long it really lasts, what genuinely helps, and how injectors prevent it.
Key Takeaways: Droopy Eyelid After Botox®
Eyelid ptosis is the most common adverse reaction listed for Botox® Cosmetic in frown-line treatment — 3% in the FDA label, not a rare event.
It happens when toxin reaches the levator palpebrae superioris, the muscle that holds the upper eyelid open.
A heavy, “hooded” look after treatment is usually brow droop, not true eyelid ptosis — different cause, different timeline, different fix.
Most cases are mild to moderate and improve over several weeks, often well before the toxin’s full effect has worn off.
Two prescription drops — apraclonidine and oxymetazoline 0.1% (Upneeq®) — can temporarily lift the lid. There is no over-the-counter equivalent.
Prevention is technique: the product labels specify staying at least 1 cm above the bony supraorbital ridge and assessing the levator before injecting.
Toxin reaching the eyelid-lifting muscle (levator palpebrae superioris) through diffusion or misplaced injection
Symptoms
Lid will not open fully; eye heaviness; visible asymmetry; a tired or “lazy eye” look; occasionally a narrowed field of vision
Onset
Typically 2–7 days after injection, occasionally up to 2 weeks
Duration
Usually improves over several weeks; at worst, fades as the product wears off (~3–4 months for most toxins, up to ~6 months for Daxxify®)
Reported frequency
3% in Botox® Cosmetic glabellar trials — the most common adverse reaction in that indication. Under 1% to ~2% for other approved toxins.
Key prevention
Injector technique, accurate dosing, correct depth and distance from the orbital rim, and a pre-treatment eyelid assessment
Educational information only. Individual risk varies with anatomy, dose, dilution and injector experience.
How Common Is Droopy Eyelid After Botox®, Really?
This is where a lot of patient-facing content gets it wrong. “Rare” is the word that gets used, but the manufacturers’ own trial data tells a different story. In the FDA prescribing information for Botox® Cosmetic, the most common adverse reactions are listed by indication — and for glabellar lines, the entry is simply eyelid ptosis (3%). For forehead lines, the label lists headache (9%) and brow ptosis (2%).
In other words, out of everything that can go mildly wrong with a frown-line treatment, a heavy eyelid is the thing most likely to happen. Think of it less like a lightning strike and more like a pothole on a familiar road: uncommon on any given trip, entirely predictable over enough trips, and almost always avoidable if the driver knows exactly where it is.
Because each toxin was studied in its own trials rather than head to head, the numbers below are not a direct ranking — different populations, doses and reporting conventions sit behind each figure. But they give a useful sense of scale.
Product
Eyelid ptosis in glabellar / upper-face trials
Notes from the label
Botox® Cosmetic (onabotulinumtoxinA)
3%
Listed as the most common adverse reaction for glabellar lines; brow ptosis 2% for forehead lines
Dysport® (abobotulinumtoxinA)
2% (vs under 1% on placebo)
Higher doses produced a higher incidence; most reports were mild to moderate and resolved over several weeks
Jeuveau® (prabotulinumtoxinA)
2% (8 of 492 patients)
No cases in the placebo group
Daxxify® (daxibotulinumtoxinA)
2% (9 of 406 patients)
Effect lasts up to about 6 months, so a complication can persist longer than with other toxins
Xeomin® (incobotulinumtoxinA)
Brow ptosis 0.7%
Eyelid ptosis did not reach the reporting threshold in the upper-facial-line trials; brow ptosis 1% with repeat treatment
Letybo® (letibotulinumtoxinA)
Under 1% (3 of 911 patients)
Brow ptosis also under 1%; the newest US approval, cleared in 2024
Figures drawn from each product’s current FDA prescribing information. Not head-to-head comparisons.
The Daxxify® wrinkle worth knowing about. A longer-lasting toxin is a longer-lasting complication. If a patient develops ptosis from a product designed to last around six months, they may live with it considerably longer than they would with a conventional toxin. That belongs in the consent conversation, not just the marketing. IAPAM’s guide to the newest FDA-approved neurotoxins covers how the current products differ in duration and dosing.
Hooded Eyes, Droopy Brow, or True Eyelid Ptosis?
A great many people who search for “hooded eyes after Botox®” do not actually have eyelid ptosis. They have a dropped eyebrow. The two look similar in the mirror and feel similar to the patient, but they are different problems with different causes, and telling them apart matters because it changes what can be done about it.
True eyelid ptosis
The upper eyelid margin itself sits lower because the levator palpebrae superioris — the muscle that lifts the lid — has been partially weakened. The eye looks smaller and the lid edge visibly covers more of the iris. This usually follows glabellar or crow’s feet treatment, where product has diffused deeper or lower than intended.
Brow ptosis (the “hooded” look)
The lid margin is where it always was, but the eyebrow has dropped. The frontalis is the only muscle that lifts the brow; relax too much of it, or relax it without balancing the muscles that pull the brow down, and the brow settles. Loose upper-lid skin then folds over and creates a hooded, heavy appearance. This typically follows forehead-line treatment and is the reason the Botox® and Xeomin® labels both instruct that forehead lines be treated in conjunction with glabellar lines rather than on their own.
A quick self-check. Look in a mirror and gently lift the eyebrow with a fingertip. If the eye opens normally and looks like its old self, the problem is the brow. If the lid margin still sits low with the brow held up, that points to true eyelid ptosis. Either way it is worth telling your injector what you found — it changes the plan.
Avoiding both is the core of balanced upper-face treatment, which is why experienced injectors plan the forehead, glabella and crow’s feet as one unit rather than three separate areas. IAPAM covers this in more depth in its guide to full-face Botox® injection strategy and facial harmony.
What Causes Droopy Eyelid After Botox®?
Botox® softens wrinkles by relaxing specific facial muscles. It does not stay perfectly still once injected — it spreads a small distance through the tissue. If it is placed too close to the eyelid, too deep, or in too large a volume, some of it can reach the levator palpebrae superioris and weaken the lid’s lifting mechanism.
Common contributing factors:
Injection placed too close or too deep around the brow or eyelid, particularly near the lateral corrugator
Too much volume or too many units in a sensitive zone — larger volumes diffuse further
Pre-existing weakness of the eyelid muscles, previous nerve injury, Bell’s palsy, or prior eyelid or brow surgery
Rubbing or massaging the treated area shortly after injection, which can move product before it binds
Anatomy — a large brow depressor complex or a heavy brow changes how much margin for error the injector has
Complications like these are precisely why anatomical depth matters more than injection speed when choosing where to train. If you are researching certification options, comparing Botox® training programs on the basis of cadaver or live-model anatomy teaching and complication management — rather than weekend-course convenience — is the more useful filter.
Injection areas and the muscles at risk
Injection area
Muscle treated
What can go wrong
Glabella (between the eyebrows)
Corrugator supercilii and procerus
Brow or eyelid droop if product is misplaced or diffuses toward the levator
Forehead lines
Frontalis
Brow ptosis and a heavy, hooded look if the frontalis is over-relaxed or treated without the glabella
Crow’s feet
Orbicularis oculi (lateral fibres)
Lateral brow or eyelid droop if placed too low, too medially, or over-treated
Outer brow / brow tail
Orbicularis oculi (lateral fibres)
Asymmetry or a dropped brow tail if dosing is uneven side to side
Effects are uncommon with correct dosing and placement. Risk varies with anatomy, dilution and injector experience.
Symptoms and Timeline
Ptosis does not appear immediately. Botulinum toxin takes days to take effect, so the droop usually shows up once the treatment itself is settling in — which is often exactly when the patient thought they were in the clear.
Symptom
Typical onset after injection
Eyelid heaviness
1–7 days
Asymmetry or a “lazy eye” appearance
1–7 days
Difficulty fully opening the eyelid
2–7 days
Dropped brow or hooded appearance
Sometimes later — 1–2 weeks
Narrowed upper field of vision
Occasional, with more pronounced cases
Timeframes vary with dose, placement and individual response. Contact your provider if symptoms are severe or worsening.
How Long Does Droopy Eyelid After Botox® Last?
The honest answer is shorter than most pages claim. Patient-facing content tends to say “three to four months” because that is how long the treatment itself lasts — but the complication and the treatment do not run on the same clock. Only a portion of the injected dose reaches the levator, so that small amount wears off sooner than the full dose in the target muscle.
The Dysport® label puts it plainly: the majority of eyelid ptosis reports were mild to moderate in severity and resolved over several weeks. Most patients see meaningful improvement in roughly three to six weeks, with the droop fading gradually rather than switching off.
Typical recovery window vs. product duration
Most ptosis improves~3–6 weeks
Most toxins wear off~3–4 months
Daxxify® wears offup to ~6 months
Illustrative ranges. The upper bars represent the outer limit — not the expected duration of a droop.
What To Do If You Have a Droopy Eyelid After Botox®
Don’t panic. The overwhelming majority of cases are temporary and self-limiting.
Contact your injector. They can document what happened, confirm whether it is lid or brow, and adjust future dosing and placement.
Ask about prescription eye drops. These are the only thing that meaningfully lifts the lid while you wait — see below.
Use artificial tears for comfort. A partially closed lid blinks less efficiently, which dries the eye.
Avoid further injections in the area until the effect has fully resolved.
Monitor. Seek medical attention if the droop affects vision, worsens, or does not begin improving after a few weeks.
The eye drops: apraclonidine and oxymetazoline (Upneeq®)
Both work the same way. Behind the main lid-lifting muscle sits a small accessory muscle called Müller’s muscle, which contributes a millimetre or two of lift and, unlike the levator, responds to adrenaline-type signals. Botulinum toxin does not affect it. A drop that stimulates it can therefore claw back a small amount of lift while the toxin wears off — a spare hinge on a door whose main hinge is temporarily stiff.
Option
What it is
Important caveats
Apraclonidine 0.5%
An alpha-adrenergic agonist, long used off-label for toxin-related ptosis
Prescription only; typically dosed several times daily; tolerance and local irritation can develop with prolonged use
Oxymetazoline 0.1% (Upneeq®)
An alpha-adrenoceptor agonist targeting Müller’s muscle; FDA-approved in 2020 for acquired blepharoptosis in adults
Prescription only; one drop once daily. Approved for acquired ptosis generally — its use specifically for toxin-related ptosis is off-label
Artificial tears
Over-the-counter lubricating drops
Comfort only. They do not lift the eyelid
Surgery
Eyelid surgery for persistent ptosis
Almost never appropriate for toxin-related ptosis, which resolves on its own. Reserved for cases that persist beyond the expected window or have another cause
There is no over-the-counter version. This is one of the most-searched questions on the topic, so it is worth being direct: both drops that actually lift the eyelid are prescription medicines. Redness-relief drops from a pharmacy shelf are not a substitute, and neither are artificial tears. Both prescription options are used off-label in this setting and should be supervised by a physician — not least because a drop that constricts blood vessels is not appropriate for every patient.
Can Botox® Be Used to Lift a Droopy or Hooded Eyelid?
It is a fair question, and the answer is a qualified yes — with the emphasis on qualified. Carefully placed injections that relax the muscles pulling the brow down allow the frontalis to raise the brow tail slightly, which opens the eye a little. Practitioners sometimes call this a chemical brow lift.
Three honest limits are worth stating plainly:
The effect is measured in millimetres, not the dramatic change a surgical lift produces.
It lifts the brow, not the eyelid. Genuine excess eyelid skin (dermatochalasis) is a surgical problem and no injectable fixes it.
The same injections done imprecisely are what causes brow droop. The technique that opens an eye and the technique that closes one are separated by a small margin, which is exactly why it belongs in experienced hands.
How To Prevent a Droopy Eyelid After Botox®
What the patient controls
Choose a certified, experienced injector with specific experience around the brow and eyes. This is the single largest risk factor, and it is the one entirely within your control.
Share your full history — prior eyelid or brow surgery, nerve injury, Bell’s palsy, any previous episode of droop, and any neuromuscular condition.
Do not rub or massage the treated areas for at least 24 hours.
Stay upright for about 4 hours after treatment.
Skip facials, brow treatments and strenuous exercise for the rest of the day.
What the injector controls: the label’s own prevention protocol
This is the part most patient-facing articles leave out, and it is the part that actually determines the outcome. The FDA prescribing information for Botox® Cosmetic contains an explicit set of steps headed “In order to reduce the complication of ptosis”. Near-identical instructions appear in the Dysport®, Xeomin®, Jeuveau®, Daxxify® and Letybo® labels.
Labeled step
Why it matters
Avoid injecting near the levator palpebrae superioris, particularly in patients with larger brow depressor complexes
The levator is the muscle whose weakening causes true ptosis; heavier brow depressors mean less margin for error
Place lateral corrugator injections at least 1 cm above the bony supraorbital ridge
The single most specific “danger zone” instruction in the label — a measurable, teachable boundary
Keep injected volume and dose accurate and, where feasible, minimal
Larger volumes diffuse further; the Dysport® label notes higher doses produced more ptosis
Treat forehead lines in conjunction with glabellar lines
Relaxing the frontalis alone drops the brow; treating the depressors alongside it keeps the balance
Angle the needle bevel up and away from the eye (Xeomin®)
Directs any spread away from the orbit
Assess the lid before injecting — check for levator separation or weakness, identify lash ptosis, and evaluate lid excursion while manually immobilising the frontalis
Reveals patients already relying on frontalis compensation, who are the highest-risk candidates
Summarised from the current FDA prescribing information for the approved botulinum toxin products. Always follow the label for the specific product in use.
That final step — the pre-injection assessment — is the one most often skipped in short-format training, and it is the one that identifies risk before a needle is uncapped. It belongs in a documented consultation routine alongside standardised photography and a structured facial analysis checklist.
A Newer Risk: Counterfeit and Mishandled Product
“Choose a qualified injector” used to be advice about technique. It is now also advice about supply chain. In April 2024, the CDC issued a Health Alert Network advisory after patients across multiple US states were hospitalised with botulism-like reactions following injections of counterfeit or mishandled botulinum toxin — in several cases administered by unlicensed people or in non-healthcare settings. The agency has continued to flag the risk as ongoing.
That matters here because the symptoms of distant toxin spread overlap with the symptoms of a complication: ptosis, double vision, generalised weakness, and difficulty swallowing, speaking or breathing. A droopy eyelid alone after a legitimate treatment is a local effect and not dangerous. A droopy eyelid combined with any of those systemic symptoms is an emergency. Knowing the product is genuine, and the injector licensed, is what lets you tell the two situations apart.
When To See a Doctor
Seek prompt medical attention if:
The droop affects your vision or is significantly worsening
It has not started improving after several weeks
There is double vision, a change in pupil size, or severe headache
You develop difficulty swallowing, speaking or breathing, or weakness elsewhere — rare, but urgent
The droop appeared without a recent injection
Why that last point matters. Ptosis is not only a cosmetic complication. The prescribing information for Upneeq® carries a specific warning that ptosis may be a presenting sign of neurologic or orbital disease including stroke, cerebral aneurysm, Horner syndrome and myasthenia gravis. A droopy lid that arrives out of nowhere deserves a medical assessment, not a cosmetic one.
Free Online Botox® Training · Earn 1 CME
Try Botox® training free. Earn 1 CME on us.
Get self-paced access to a real IAPAM Botox® module — watch step-by-step injection technique, follow along with our physician instructors, and claim 1 AMA PRA Category 1 CME when you finish.
Enter your details and we’ll email your access link.
Frequently Asked Questions
How common is a droopy eyelid after Botox®?
More common than most people assume. Eyelid ptosis is listed at 3% in the FDA prescribing information for Botox® Cosmetic in glabellar (frown line) treatment, where it is the most commonly reported adverse reaction. Rates across other approved toxins run from under 1% to about 2%. Skilled technique lowers the risk but does not remove it.
Is it a droopy eyelid or a droopy eyebrow?
They are different problems. True eyelid ptosis means the lid margin itself sits lower because the levator palpebrae superioris has been weakened. Brow ptosis means the eyebrow has dropped, usually after forehead treatment, pushing loose lid skin down and creating a hooded look while the lid margin stays where it was. A simple test: if lifting the eyebrow with a fingertip opens the eye normally, the problem is the brow, not the lid.
How long does a droopy eyelid after Botox® last?
Most cases are mild to moderate and improve over several weeks rather than persisting for the full life of the treatment. The Dysport® label notes that the majority of eyelid ptosis reports were mild to moderate and resolved over several weeks. Worst case, the droop fades as the product wears off, which is roughly three to four months for most toxins and up to about six months for Daxxify®.
What eye drops help a droopy eyelid after Botox®?
Two prescription drops are used: apraclonidine 0.5% and oxymetazoline 0.1% (Upneeq®). Both work by stimulating Müller’s muscle, a small accessory muscle that can pull the lid up a millimetre or two. Oxymetazoline is FDA-approved for acquired blepharoptosis in adults; its use for toxin-related ptosis, like apraclonidine’s, is off-label and should be supervised by a physician.
Are there over-the-counter eye drops for a droopy eyelid after Botox®?
No. Both drops that lift the eyelid are prescription-only. Over-the-counter artificial tears help with dryness and irritation but do nothing for the droop itself, and redness-relief drops are not a substitute. If you want the lid lifted, that is a conversation with your injector or an eye doctor.
Can Botox® be used to lift a hooded or droopy eyelid?
In a limited way. Relaxing the muscles that pull the brow down can let the brow tail sit a little higher, which opens the eye slightly. This is a modest effect measured in millimetres, it lifts the brow rather than the lid, and it does nothing for excess eyelid skin, which is a surgical issue. The same injections done imprecisely are also what causes brow droop, so it is technique-dependent work.
When is a droopy eyelid something more serious?
Ptosis can be a presenting sign of neurologic or orbital disease including stroke, cerebral aneurysm, Horner syndrome and myasthenia gravis. Seek prompt medical attention if the droop appears without a recent injection, comes with double vision, a different pupil size, severe headache, drooping elsewhere in the face, or any difficulty swallowing, speaking or breathing.
Conclusion: Droopy Eyelid After Botox® (Ptosis)
A droopy eyelid after Botox® is not rare — it is the most common thing the label expects to go wrong in frown-line treatment — but it is temporary, it usually improves in weeks rather than months, and it is overwhelmingly preventable. Almost every protective factor comes down to the same thing: an injector who understands the anatomy, measures the distance from the orbital rim, screens the eyelid before injecting, and treats the upper face as one balanced unit.
If you are already experiencing it, contact your injector, ask whether prescription drops are appropriate for you, and give it a few weeks. If you are a provider who wants the anatomical depth and complication management that prevents it in the first place, IAPAM’s hands-on Botox® training in Scottsdale, Arizona teaches injection technique on live models with board-certified physician instructors — including how to recognise the patients where the margin for error is smallest.
Disclaimer: This guide is for informational and educational purposes only and does not constitute medical advice. Treatment plans, injection techniques, and dosing must be tailored to each patient by a qualified, licensed provider. Always follow product labeling, your scope of practice, and your state medical and nursing board regulations.
Dr. Haley is a board-certified dermatologist with more than 20 years of experience in medical, cosmetic, and surgical dermatology. A former division head of academic dermatology at the National Naval Medical Center in Bethesda, she now trains licensed healthcare professionals in cosmetic injectables as an IAPAM clinical injection trainer.
Compare Botox® certification levels — basic, intermediate & advanced training. Learn what each level covers, who it’s for, and how to choose the right program.
Learn Botox® continuing education requirements for physicians, NPs, PAs, and dentists — how many CME/CE credits you need and how to choose quality training.
Master full face Botox injection strategy: unit planning, sequencing, and how to balance the upper, mid, and lower face for natural, harmonious results.
Attend IAPAM’s comprehensive AMA PRA Category 1 CME BOTOX® training weekend and learn the clinical and business foundations for aesthetic practice growth.
✓Hands-on BOTOX® injection training in a clean, multi-million-dollar medspa—not a hotel.
✓Live models and product are provided so you can focus on learning with expert instructors.
✓Build foundations in five non-invasive treatments, with an optional GLP-1 weight-management business add-on.
